Parallax Volatility Advisers
RXII

Parallax Volatility Advisers’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Parallax Volatility Advisers’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-121,000
Closed -$165K – 4175
2016
Q1 		$165K Hold
121,000
– – ﹤0.01% 1818
2015
Q4 		$178K Buy
+121,000
New +$178K ﹤0.01% 1930

Parallax Volatility Advisers's RXII Position: Q2 2016 in Review

Parallax Volatility Advisers sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2016, closing a stake of 108,791 shares — an estimated $148K sold.

Parallax Volatility Advisers first reported a position in RXII in Q4 2015 and held it in 2 quarters. The position peaked at $148K in Q1 2016. 90 funds tracked by Wall St. Rank hold RXII as of Q2 2016.

  • Parallax Volatility Advisers reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2016 after selling out during the quarter.
  • Parallax Volatility Advisers sold 108,791 GALENA BIOPHARMA INC COM shares in Q2 2016, an estimated $148K.
  • Parallax Volatility Advisers first reported a position in GALENA BIOPHARMA INC COM in Q4 2015 and held it in 2 quarters.
  • Parallax Volatility Advisers's GALENA BIOPHARMA INC COM position peaked at $148K in Q1 2016.
  • 90 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2016.

Based on Parallax Volatility Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.